Top Markets
#1 Black Phoenix Black Phoenix +342.81%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +61.75%
#4 Gold Park Gold Park +55.03%
#5 Acurast Acurast +36.76%
#6 BasedHype BasedHype +29.90%
#7 Cryptopia Cryptopia +22.04%
#8 Avantis Avantis +20.86%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +14.74%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Pozycja w akcjach #41092
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Cena akcji
$0.0202
Ostatnia synchronizacja: 2024-11-19
Kapitalizacja rynkowa
$44.67K
Zmiana (1 dzień)
-0.49%
Zmiana (1 rok)
0.00%
Kraj
IL
Handel Notable Labs, Ltd. (NTBL)

Kategoria

Healthcare
Przychody dla Notable Labs, Ltd. (NTBL)
Przychody w Jun 2024 TTM: $3.00K
Według najnowszych raportów finansowych Notable Labs, Ltd., obecny przychód firmy (TTM) wynosi $3.00K. W roku 2022 firma osiągnęła przychód w wysokości $8.00K spadek w porównaniu do przychodu z roku 2021, który wynosił $285.00K. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Notable Labs, Ltd. od 2015 do 2026
Przychody na koniec każdego roku
Rok Przychody Zmień
2026 (TTM) $3.00K -99.03%
2023 $310.00K 3,775.00%
2022 $8.00K -97.19%
2021 $285.00K -69.09%
2020 $922.00K 64.06%
2019 $562.00K -3.93%
2018 $585.00K -95.78%
2017 $13.86M 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
Przychody podobnych firm lub konkurentów
Firma Przychody Różnica w przychodach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 420,809,900.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 200,709,476.97%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 337,026,123.20%
BE